Russia’s Sputnik V vaccine has ‘high efficacy’ of 91.6 per cent, according to Lancet study

Scientists gave Russia’s Sputnik V vaccine the green light on Tuesday saying it was almost 92 per cent effective in fighting COVID-19 based on peer-reviewed late-stage trial results published in The Lancet international medical journal.